These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 17692936)
1. The novel peptide apelin regulates intrarenal artery tone in diabetic mice. Zhong JC; Huang Y; Yung LM; Lau CW; Leung FP; Wong WT; Lin SG; Yu XY Regul Pept; 2007 Dec; 144(1-3):109-14. PubMed ID: 17692936 [TBL] [Abstract][Full Text] [Related]
2. Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice. Zhong JC; Yu XY; Huang Y; Yung LM; Lau CW; Lin SG Cardiovasc Res; 2007 Jun; 74(3):388-95. PubMed ID: 17359956 [TBL] [Abstract][Full Text] [Related]
3. Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans. Dray C; Debard C; Jager J; Disse E; Daviaud D; Martin P; Attané C; Wanecq E; Guigné C; Bost F; Tanti JF; Laville M; Vidal H; Valet P; Castan-Laurell I Am J Physiol Endocrinol Metab; 2010 Jun; 298(6):E1161-9. PubMed ID: 20233941 [TBL] [Abstract][Full Text] [Related]
4. Effects of olmesartan on Apelin/APJ and Akt/endothelial nitric oxide synthase pathway in Dahl rats with end-stage heart failure. Fukushima H; Kobayashi N; Takeshima H; Koguchi W; Ishimitsu T J Cardiovasc Pharmacol; 2010 Jan; 55(1):83-8. PubMed ID: 19904215 [TBL] [Abstract][Full Text] [Related]
5. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension. Georgescu A; Popov D; Dragan E; Dragomir E; Badila E Eur J Pharmacol; 2007 Sep; 570(1-3):149-58. PubMed ID: 17612521 [TBL] [Abstract][Full Text] [Related]
6. Impairment of the vascular relaxation and differential expression of caveolin-1 of the aorta of diabetic +db/+db mice. Lam TY; Seto SW; Lau YM; Au LS; Kwan YW; Ngai SM; Tsui KW Eur J Pharmacol; 2006 Sep; 546(1-3):134-41. PubMed ID: 16904102 [TBL] [Abstract][Full Text] [Related]
8. IL-6 deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy. Schrader LI; Kinzenbaw DA; Johnson AW; Faraci FM; Didion SP Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2576-81. PubMed ID: 17962626 [TBL] [Abstract][Full Text] [Related]
9. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in metabolic disorders: hypercholesterolaemia and diabetes]. Strawn WB Drugs; 2002; 62 Spec No 1():31-41. PubMed ID: 12036387 [TBL] [Abstract][Full Text] [Related]
10. Angiopoietin-1 gene transfer improves impaired wound healing in genetically diabetic mice without increasing VEGF expression. Bitto A; Minutoli L; Galeano MR; Altavilla D; Polito F; Fiumara T; Calò M; Lo Cascio P; Zentilin L; Giacca M; Squadrito F Clin Sci (Lond); 2008 Jun; 114(12):707-18. PubMed ID: 18078386 [TBL] [Abstract][Full Text] [Related]
11. Non-activated APJ suppresses the angiotensin II type 1 receptor, whereas apelin-activated APJ acts conversely. Sun X; Iida S; Yoshikawa A; Senbonmatsu R; Imanaka K; Maruyama K; Nishimura S; Inagami T; Senbonmatsu T Hypertens Res; 2011 Jun; 34(6):701-6. PubMed ID: 21412239 [TBL] [Abstract][Full Text] [Related]
12. Effect of hyperhomocystinemia and hypertension on endothelial function in methylenetetrahydrofolate reductase-deficient mice. Virdis A; Iglarz M; Neves MF; Amiri F; Touyz RM; Rozen R; Schiffrin EL Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1352-7. PubMed ID: 12829522 [TBL] [Abstract][Full Text] [Related]
13. Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency. Yagi S; Aihara K; Ikeda Y; Sumitomo Y; Yoshida S; Ise T; Iwase T; Ishikawa K; Azuma H; Akaike M; Matsumoto T Circ Res; 2008 Jan; 102(1):68-76. PubMed ID: 17967781 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin type 1 receptor is linked to inhibition of nitric oxide production in pulmonary endothelial cells. Zhao X; Li X; Trusa S; Olson SC Regul Pept; 2005 Dec; 132(1-3):113-22. PubMed ID: 16242794 [TBL] [Abstract][Full Text] [Related]
15. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis. Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051 [TBL] [Abstract][Full Text] [Related]
16. Opposing roles of p47phox in basal versus angiotensin II-stimulated alterations in vascular O2- production, vascular tone, and mitogen-activated protein kinase activation. Li JM; Wheatcroft S; Fan LM; Kearney MT; Shah AM Circulation; 2004 Mar; 109(10):1307-13. PubMed ID: 14993144 [TBL] [Abstract][Full Text] [Related]